BioSpace News Archive

The West Virginia Mesothelioma Victims Center says, “We are now urging a person anywhere in West Virginia who has just been diagnosed with mesothelioma, asbestos exposure lung cancer or their family to call us anytime at 800-714-0303 for direct access to attorney Erik Karst, found partner of the law firm Karst von Oiste.

Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announces today that seven poster presentations from its Alzheimer’s disease/dementia pipeline will be highlighted at the 14th International Conference on Alzheimer’s & Parkinson’s Diseases (AD/PD) on March 26-31 in Lisbon, Portugal.

A leading quality rating for the nation’s hospitals appears not to adequately account for the risks of undergoing certain procedures at certain hospitals, particularly joint replacement surgery, according to a new study

In a breakthrough for Long Island women diagnosed with breast cancer, NYU Winthrop Hospital today announced that is has been named Long Island’s first Hidden Scar® Center of Excellence in recognition of the hospital now offering an advanced approach to breast cancer surgery that removes cancerous tissue but hides visible scarring.

OncLive®, the nation’s leading digital resource focused on providing oncology professionals with the most current and insightful information they need to provide the best patient care, will host its latest State of the Science Summit™ on ovarian cancer and soft tissue sarcoma Tuesday, March 26, from 5 to 9 p.m. at the Millennium Hilton New York in New York City.

Walgreens is supporting relief efforts in Iowa and Nebraska as communities across the region continue to recover from record flooding.

The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes its 2018 IFRS annual results,

ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets, today reported financial results for the quarter and full year ended 31 December 2018 and provided an update on its clinical activities.

“Health insurance helps individuals access the care they need, at the right time and in the right healthcare setting. That is essential to ensure better health for the people of New Jersey

the Tuberous Sclerosis Alliance will present its 18th Annual Comedy for a Cure®, which raises funds to support research into a rare disease called tuberous sclerosis complex.